Literature DB >> 15013117

Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction.

T Sloane Guy1, Sina L Moainie, Joseph H Gorman, Benjamin M Jackson, Theodore Plappert, Yoshiharu Enomoto, Martin G St John-Sutton, L Henry Edmunds, Robert C Gorman.   

Abstract

OBJECTIVES: This study was designed to test the hypothesis that ischemic mitral regurgitation (IMR) results from, but does not influence, the progression of left ventricular (LV) remodeling after posterolateral infarction.
BACKGROUND: Surgical correction of chronic IMR is being increasingly recommended.
METHODS: Three groups of sheep had coronary snares placed around the second and third obtuse marginal coronary arteries. Occlusion of these vessels in the control group resulted in progressive IMR over eight weeks. In a second group, Merseline mesh was fitted to cover the exposed LV before infarction. In a third group, a ring annuloplasty was placed before infarction to prevent IMR. Remodeling and degree of IMR were assessed with echocardiography at baseline and at 30 min and two, five, and eight weeks after infarction.
RESULTS: Eight weeks after infarction, mean IMR grade was significantly higher in control animals than mesh and annuloplasty animals. At eight weeks, LV end-systolic volume and end-systolic muscle-to-cavity-area ratio (ESMCAR) were significantly better in mesh-treated sheep than in control sheep; also, at eight weeks, ESMCAR and akinetic segment length were significantly better in mesh-treated sheep than in annuloplasty sheep. Ejection fraction was significantly higher in the mesh than the annuloplasty group. There was no significant difference in any measure of remodeling between the annuloplasty and control groups.
CONCLUSIONS: Prophylactic ventricular restraint reduces infarct expansion, attenuates adverse remodeling, and reduces IMR severity. Prevention of IMR by prophylactic ring annuloplasty does not influence remodeling. Ischemic mitral regurgitation is a consequence, not a cause, of postinfarction remodeling; infarct expansion is the more important therapeutic target.

Entities:  

Mesh:

Year:  2004        PMID: 15013117     DOI: 10.1016/j.jacc.2003.07.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  Pathophysiology of ischemic mitral insufficiency: does repair make a difference?

Authors:  Joseph H Gorman; Liam P Ryan; Robert C Gorman
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

2.  The effect of pure mitral regurgitation on mitral annular geometry and three-dimensional saddle shape.

Authors:  Tom C Nguyen; Akinobu Itoh; Carl J Carlhäll; Wolfgang Bothe; Tomasz A Timek; Daniel B Ennis; Robert A Oakes; David Liang; George T Daughters; Neil B Ingels; D Craig Miller
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

3.  Moderate mitral regurgitation accelerates left ventricular remodeling after posterolateral myocardial infarction.

Authors:  Mehrdad Soleimani; Michael Khazalpour; Guangming Cheng; Zhihong Zhang; Gabriel Acevedo-Bolton; David A Saloner; Rakesh Mishra; Arthur W Wallace; Julius M Guccione; Liang Ge; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2011-09-25       Impact factor: 4.330

Review 4.  Is ischemic mitral regurgitation an indication for surgical repair or replacement?

Authors:  A Marc Gillinov
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

Review 5.  Why Is Infarct Expansion Such an Elusive Therapeutic Target?

Authors:  William J Richardson; Jeffrey W Holmes
Journal:  J Cardiovasc Transl Res       Date:  2015-09-21       Impact factor: 4.132

6.  Saddle-Shaped Annuloplasty Improves Leaflet Coaptation in Repair for Ischemic Mitral Regurgitation.

Authors:  Wobbe Bouma; Chikashi Aoki; Mathieu Vergnat; Alison M Pouch; Shanna R Sprinkle; Matthew J Gillespie; Massimo A Mariani; Benjamin M Jackson; Robert C Gorman; Joseph H Gorman
Journal:  Ann Thorac Surg       Date:  2015-07-14       Impact factor: 4.330

7.  Polymer injection therapy to reverse remodel the papillary muscles: efficacy in reducing mitral regurgitation in a chronic ischemic model.

Authors:  Jorge Solis; Robert A Levine; Benjamin Johnson; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Kaitlyn Lam; Jason Berlin; Gavin J C Braithwaite; Orhun K Muratoglu; Gus J Vlahakes; Judy Hung
Journal:  Circ Cardiovasc Interv       Date:  2010-08-24       Impact factor: 6.546

8.  Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model.

Authors:  Kanji Matsuzaki; Masato Morita; Hirotsugu Hamamoto; Mio Noma; J Daniel Robb; Matthew J Gillespie; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

Review 9.  Physiological Implications of Myocardial Scar Structure.

Authors:  William J Richardson; Samantha A Clarke; T Alexander Quinn; Jeffrey W Holmes
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

10.  A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles.

Authors:  Judy Hung; Jorge Solis; J Luis Guerrero; Gavin J C Braithwaite; Orhun K Muratoglu; Miguel Chaput; Leticia Fernandez-Friera; Mark D Handschumacher; Van J Wedeen; Stuart Houser; Gus J Vlahakes; Robert A Levine
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.